5-year follow-up checks if imlifidase helps kidney transplants last longer

NCT ID NCT05937750

Ongoing Disease control Sponsor: Hansa Biopharma AB Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 150 people who received imlifidase before a kidney transplant to see how long their new kidney works. Researchers will check for graft failure (return to dialysis, re-transplant, or kidney removal) over 5 years. A separate group of similar patients not receiving imlifidase is also included for comparison.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LONG TERM EFFICACY AND SAFETY

Contacts and locations

Locations

Azienda Ospedaliera di Padova

Padova, 35128, Italy
Azienda Ospedaliero - Universitaria di Parma

Parma, 43100, Italy
Centre Hospitalier Universitaire (CHU) de Rouen - Hôpital de Bois-Guillaume

Bois-Guillaume, Normandy, 76230, France
Erasmus University Medical Center

Rotterdam, 3015 GD, Netherlands
Hospital Del Mar, Servicio de Nefrología

Barcelona, 08003, Spain
Hospital Universitario 12 De Octubre

Madrid, 28041, Spain
Hospital Universitario del Vall d´Hebron

Barcelona, 08035, Spain
Hôpital Necker - Enfants Malades

Paris, 75015, France
Karolinska University Hospital,

Huddinge, Stockholm County, 14157, Sweden
Leiden University Medical Center

Leiden, 2333 ZA, Netherlands
Medizinische Universitaet Wien

Vienna, 1090, Austria
Nephrology Clinic Vídeňská 1958/9

Prague, 140-21, Czechia
Unidad de Trasplante Renal

Barcelona, 08036, Spain
Uppsala University Hospital

Uppsala, 751 85, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.